Brain, Vol. 123, No. 7, 1365-1379,
July 2000
© 2000 Oxford University Press
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
1 Neurodegenerative Disorders Centre, Vancouver Hospital and Health Sciences Centre, Vancouver, Canada and 2 Wallenberg Neuroscience Center, University of Lund, Lund, Sweden
Correspondence to:
Dr Chong S. Lee, Neurodegenerative Disorders Centre, Purdy Pavilion, 2221 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5 E-mail: cslee{at}interchange.ubc.ca
We investigated the role of dopamine neurons in the manifestation of levodopa-induced dyskinesia in a rat model of Parkinson's disease. Daily treatment with a subthreshold dose of levodopa gradually induced abnormal involuntary movements (AIM) in 6-hydroxydopamine-lesioned rats, which included stereotypy and contraversive rotation. After 4 weeks of levodopa treatment, rats with mild and severe AIM were assigned to two treatment subgroups. The graft subgroup received embryonic ventral mesencephalic tissue into the striatum, whilst the sham-graft subgroup received vehicle only. Rats continued to receive levodopa treatment for 3 months post-graft. Brain sections at the level of the basal ganglia were processed for autoradiography using a ligand for dopamine transporter, and in situ hybridization histochemistry for mRNAs encoding postsynaptic markers. Levodopa-induced AIM significantly improved in grafted rats. The severity of AIM correlated inversely with the density of dopamine nerve terminals in the striatum (P < 0.001), with almost no AIM when the density of dopamine nerve terminals was >10–20% of normal. Embryonic dopamine neuronal grafts normalized not only mRNA expression for preproenkephalin (PPE) in the indirect pathway, but also mRNA expression for prodynorphin (PDyn) in the direct pathway, which was upregulated by levodopa treatment. AIM scores correlated linearly with expression of PPE mRNA in the indirect pathway (P < 0.001) and also with PDyn mRNA in the direct pathway (P < 0.001). We conclude that embryonic dopamine neuronal grafts may improve levodopa-induced dyskinesia by restoring altered activities of postsynaptic neurons, resulting not only from dopamine denervation, but also from levodopa therapy, provided that the density of striatal dopaminergic nerve terminals is restored above a `threshold' level.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Carlsson, M. Carta, A. Munoz, B. Mattsson, C. Winkler, D. Kirik, and A. Bjorklund Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration Brain, February 1, 2009; 132(2): 319 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Munoz, Q. Li, F. Gardoni, E. Marcello, C. Qin, T. Carlsson, D. Kirik, M. Di Luca, A. Bjorklund, E. Bezard, et al. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia Brain, December 1, 2008; 131(12): 3380 - 3394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vinuela, P. J. Hallett, C. Reske-Nielsen, M. Patterson, T. D. Sotnikova, M. G. Caron, R. R. Gainetdinov, and O. Isacson Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease Brain, December 1, 2008; 131(12): 3361 - 3379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wernig, J.-P. Zhao, J. Pruszak, E. Hedlund, D. Fu, F. Soldner, V. Broccoli, M. Constantine-Paton, O. Isacson, and R. Jaenisch Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease PNAS, April 15, 2008; 105(15): 5856 - 5861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Putterman, A. C. Munhall, L. B. Kozell, J. K. Belknap, and S. W. Johnson Evaluation of Levodopa Dose and Magnitude of Dopamine Depletion as Risk Factors for Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Carlsson, M. Carta, C. Winkler, A. Bjorklund, and D. Kirik Serotonin Neuron Transplants Exacerbate L-DOPA- Induced Dyskinesias in a Rat Model of Parkinson's Disease J. Neurosci., July 25, 2007; 27(30): 8011 - 8022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carta, T. Carlsson, D. Kirik, and A. Bjorklund Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain, July 1, 2007; 130(7): 1819 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Buhnemann, A. Scholz, C. Bernreuther, C. Y. Malik, H. Braun, M. Schachner, K. G. Reymann, and M. Dihne Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats Brain, December 1, 2006; 129(12): 3238 - 3248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Carlsson, C. Winkler, C. Burger, N. Muzyczka, R. J. Mandel, A. Cenci, A. Bjorklund, and D. Kirik Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors Brain, March 1, 2005; 128(3): 559 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Olanow Present and future directions in the management of motor complications in patients with advanced PD Neurology, September 23, 2003; 61(90063): S24 - 33. [Full Text]
|
|
|
|
|
|
M. Andersson, C. Konradi, and M. A. Cenci cAMP Response Element-Binding Protein Is Required for Dopamine-Dependent Gene Expression in the Intact But Not the Dopamine-Denervated Striatum J. Neurosci., December 15, 2001; 21(24): 9930 - 9943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Olanow, T. Freeman, J. Kordower, D. E. Redmond Jr., J. R. Sladek, D. D. Spencer, C. R. Freed, R. E. Breeze, and S. Fahn Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease N. Engl. J. Med., July 12, 2001; 345(2): 146 - 147. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Bjorklund, R. Sanchez-Pernaute, S. Chung, T. Andersson, I. Y. C. Chen, K. St. P. McNaught, A.-L. Brownell, B. G. Jenkins, C. Wahlestedt, K.-S. Kim, et al. From the Cover: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model PNAS, February 19, 2002; 99(4): 2344 - 2349. [Abstract] [Full Text] [PDF]
|
|